Abstract
Proprotein convertase subtilisin kexin type 9 (PCSK9) targets the degradation of low-density lipoprotein (LDL) receptors; it has been proved that its ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
